|
BCKDK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.2912782782214E-12 |
| Normal-vs-Stage2 |
9.031800E-04 |
| Normal-vs-Stage3 |
2.70100000032691E-07 |
| Normal-vs-Stage4 |
3.118400E-02 |
| Stage1-vs-Stage2 |
6.546000E-01 |
| Stage1-vs-Stage3 |
1.000360E-02 |
| Stage1-vs-Stage4 |
8.933000E-01 |
| Stage2-vs-Stage3 |
1.354580E-01 |
| Stage2-vs-Stage4 |
8.614200E-01 |
| Stage3-vs-Stage4 |
1.772970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.38999999996526E-06 |
| Normal-vs-Asian |
4.328600E-01 |
| Caucasian-vs-AfricanAmerican |
1.686020E-01 |
| Caucasian-vs-Asian |
3.616600E-01 |
| AfricanAmerican-vs-Asian |
6.883800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
9.98312543742941E-12 |
| Male-vs-Female |
5.106100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.85118999999068E-05 |
| Normal-vs-Extreme_Weight |
8.35269631238589E-11 |
| Normal-vs-Obese |
4.92829999032551E-09 |
| Normal-vs-Extreme_Obese |
1.407250E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.461000E-01 |
| Normal_Weight-vs-Obese |
2.531800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.307800E-01 |
| Extreme_Weight-vs-Obese |
2.820000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.446800E-01 |
| Obese-vs-Extreme_Obese |
4.852000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.456400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.55986334959834E-13 |
| Normal-vs-Age(61-80Yrs) |
1.64324109874769E-12 |
| Normal-vs-Age(81-100Yrs) |
1.543790E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.220200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.907600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.857800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.310200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.249600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.576000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.14679999940748E-08 |
| Normal-VS-KIRP CIMP |
2.752000E-02 |
| Normal-VS-Unclassified PRCC |
1.51202999999489E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.587200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.639000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.955800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.617800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.451400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.668200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40849999996639E-06 |
| Normal-vs-N1 |
1.523240E-03 |
| Normal-vs-N2 |
7.374400E-02 |
| N0-vs-N1 |
6.785600E-01 |
| N0-vs-N2 |
2.938600E-01 |
| N1-vs-N2 |
1.927850E-01 |
|
|
